KNG1 and angioedema: These measures will be insufficient for patients with bradykinin-mediated angioedema; however, these patients will require treatment with medications such as C1 esterase inhibitor concentrates, kallikrein inhibitors, and bradykinin-2-receptor antagonists [6,22,23].